Literature DB >> 18813782

Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met.

Y Onimaru1, K Tsukasaki, K Murata, Y Imaizumi, Y L Choi, H Hasegawa, K Sugahara, Y Yamada, T Hayashi, M Nakashima, T Taguchi, H Mano, S Kamihira, M Tomonaga.   

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is a neoplasia characterized by the massive invasion of various organs by tumor cells. Previously, we found that expression of the gene for c-Met, a receptor tyrosine kinase for hepatocyte growth factor (HGF), was specific to the acute type among 41 patients with ATLL by microarray. First in the present study, we analyzed the survival of the patients in relation to expression of c-Met and HGF in ATLL cells. Expression of the former but not the latter was associated with poor prognosis. Then, we analyzed the growth of ATLL cells caused by HGF and c-Met. c-Met was expressed in 0/7 chronic ATLLs, 12/14 acute ATLLs, 1/1 IL-2-independent ATLL cell line and 1/7 IL-2-dependent ATLL cell lines as assessed by flow cytometry. HGF induced the proliferation of primary cells from most acute cases examined as well as the c-Met-positive KK1 cell line in contrast to c-Met-negative cells. HGF induced autophosphorylation of c-Met in c-Met-positive cells from an acute case and KK1 cells. The plasma level of HGF was elevated in acute as compared to chronic cases. The levels of HGF and/or IL-6 which induces the production of HGF by stromal cells, were elevated in the supernatant of short-term cultured cells from certain patients with acute or chronic disease. Finally, infiltrated ATLL cells and adjacent stromal cells in liver were shown to be positive for c-Met/HGF and HGF, respectively, in acute cases. Autocrine and/or paracrine growth caused by HGF and c-Met was suggested in aggressive ATLL cells secreting HGF and/or IL-6, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18813782

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  RhoA-mediated signaling up-regulates hepatocyte growth factor gene and protein expression in response to apoptotic cells.

Authors:  Hyun-Jung Park; Youn-Hee Choi; Young Joo Cho; Peter M Henson; Jihee Lee Kang
Journal:  J Leukoc Biol       Date:  2010-12-10       Impact factor: 4.962

2.  Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.

Authors:  Jonathan L Berkowitz; John E Janik; Donn M Stewart; Elaine S Jaffe; Maryalice Stetler-Stevenson; Joanna H Shih; Thomas A Fleisher; Maria Turner; Nicole E Urquhart; Gilian H Wharfe; William D Figg; Cody J Peer; Carolyn K Goldman; Thomas A Waldmann; John C Morris
Journal:  Clin Immunol       Date:  2014-09-28       Impact factor: 3.969

3.  Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma.

Authors:  Haruhito Totani; Keiko Shinjo; Miho Suzuki; Keisuke Katsushima; Shoko Mase; Ayako Masaki; Asahi Ito; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Takashi Ishida; Hiroshi Inagaki; Shinsuke Iida; Yutaka Kondo
Journal:  Oncogene       Date:  2020-08-04       Impact factor: 9.867

Review 4.  MET: a promising anticancer therapeutic target.

Authors:  Solange Peters; Alex A Adjei
Journal:  Nat Rev Clin Oncol       Date:  2012-05-08       Impact factor: 66.675

5.  Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo.

Authors:  Shyamesh Kumar; Dusan Kunec; Joram J Buza; Hsin-I Chiang; Huaijun Zhou; Sugalesini Subramaniam; Ken Pendarvis; Hans H Cheng; Shane C Burgess
Journal:  BMC Syst Biol       Date:  2012-09-14

Review 6.  The role of HGF/c-MET signaling pathway in lymphoma.

Authors:  Bao Quoc Lam; Lu Dai; Zhiqiang Qin
Journal:  J Hematol Oncol       Date:  2016-12-07       Impact factor: 17.388

7.  Interaction of perforin and granzyme B and HTLV-1 viral factors is associated with Adult T cell Leukemia development.

Authors:  Mohammad Mehdi Akbarin; Sadegh Farhadi; Abolghasem Allahyari; Mohammad Mehdi Koshayar; Abbas Shirdel; Hossein Rahimi; Seyed Abdolrahim Rezaee; Maryam Mahdifar; Zahra Mozaheb; Asadollah Mohamadi; Alireza Bari; SeyedehTahereh Mohaddes; Houshang Rafatpanah
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.